We validate response-biomarkers for chemo- and targeted-therapy using cell culture models and clinical sample biobanks for breast, ovarian, and brain cancers.

Used technologies:

• Cell culture
• Cell proliferation and viability assays
• RNA interference
• RT-PCR
• Immunhistochemistry
• FACS
• Cell invasion assays
• Illumina next generation sequencing